Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), bought 5,000 shares at $9.74 ($49K) on 2022-02-02, disclosed to the SEC on 2022-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |